Bentham Science Logo

Track Your Manuscript:


Clinical Cancer Drugs

Volume 7, 2 Issues, 2020
ISSN: 2212-6988 (Online)
ISSN: 2212-697X (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current Pandemic scenario, all articles related to Coronavirus will be processed on a quick track basis, to ensure timely review and publication of much needed research

Aims & Scope

Clinical Cancer Drugs publishes original research, full-length reviews/ mini reviews, and thematic issues in all core areas of translational and clinical cancer drug research.

The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading for clinical oncologists, toxicologists, medicinal chemists, and pharmacologists.

Author Guidelines


Editor-in-Chief

Giulio Francia
The University of Texas
El Paso, TX
(USA)

Biography View Full Editorial Board

Journal History

Clinical Cancer Drugs was introduced in 2014 with the assistance of Dr. Giulio Francia, who is the current Editor-in-Chief serving since 2014.

Advertisement

Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog